GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Vaccine Inc (SZSE:301207) » Definitions » Change In Receivables

Hualan Biological Vaccine (SZSE:301207) Change In Receivables : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Hualan Biological Vaccine Change In Receivables?

Hualan Biological Vaccine's change in receivables for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Hualan Biological Vaccine's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Hualan Biological Vaccine's change in receivables for the fiscal year that ended in Dec. 2024 was ¥884 Mil. It means Hualan Biological Vaccine's Accounts Receivable declined by ¥884 Mil from Dec. 2023 to Dec. 2024 .

Hualan Biological Vaccine's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥1,276 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hualan Biological Vaccine's Days Sales Outstanding for the three months ended in Mar. 2025 was 4,795.27.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hualan Biological Vaccine's liquidation value for the three months ended in Mar. 2025 was ¥1,918 Mil.


Hualan Biological Vaccine Change In Receivables Historical Data

The historical data trend for Hualan Biological Vaccine's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Vaccine Change In Receivables Chart

Hualan Biological Vaccine Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial -906.30 89.38 -380.76 -224.19 884.47

Hualan Biological Vaccine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hualan Biological Vaccine Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hualan Biological Vaccine  (SZSE:301207) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hualan Biological Vaccine's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1276.094/24.283*91
=4,795.27

2. In Ben Graham's calculation of liquidation value, Hualan Biological Vaccine's accounts receivable are only considered to be worth 75% of book value:

Hualan Biological Vaccine's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=2199.453-1395.441+0.75 * 1276.094+0.5 * 313.505
=1,918

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hualan Biological Vaccine Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hualan Biological Vaccine's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Vaccine Business Description

Traded in Other Exchanges
N/A
Address
No. 1, No. 1, Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Hualan Biological Vaccine Inc is engaged in Research, development, production and sales of human vaccines.
Executives
Lou Yuan Cheng Supervisors

Hualan Biological Vaccine Headlines

No Headlines